Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Chembio DPP™ Zika IgM Assay System

The 15-minute rapid test for detecting Zika virus infection

Manufacturer:  Chembio 6595550

Catalog No. 23-999-106


Due to product restrictions, please to purchase or view availability for this product.


Includes: 20 Individually Pouched DPP™ Zika IgM Test Devices, 20 Disposable 10µL Microsafe™ Tubes, 20 Sample Vials, 20 Transfer Pipets (100µL), 1 DPP IgM Sample Buffer, Blue Cap, 1 DPP IgM Running Buffer, Yellow Cap, 1 Product Insert, 1 Quick Reference Guide, Fact sheet for patients, Fact sheet for Health care workers
This item is not returnable. View return policy

Description

Description

 
For the detection of Zika virus IgM antibodies in fingerstick whole blood, EDTA venous whole blood, EDTA plasma and serum. 
  • Fast:  Provides results in as little as 15 minutes
  • Flexible: Detects Zika virus IgM antibodies from 8 days up to 12 weeks
  • Easy to Use: Provides objective results using simple, handheld digital reader (DPP™ Micro Reader)
  • Received FDA Emergency Use Authorization (EUA)
Specifications

Specifications

2°C to 8°C
IgM Antibodies to Zika virus
20 Individually Pouched DPP™ Zika IgM Test Devices, 20 Disposable 10μL Microsafe™ Tubes, 20 Sample Vials, 20 Transfer Pipets (100μL), 1 DPP IgM Sample Buffer, Blue Cap, 1 DPP IgM Running Buffer, Yellow Cap, 1 Product Insert, 1 Quick Reference Guide, Fact sheet for patients, Fact sheet for Health care workers
Rapid Test
Detection of Zika virus infection in Fingerstick Whole Blood, Venous Whole blood, Serum, Plasma
20
SDS
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

i.   The test has not been FDA cleared or approved; 
ii.  The test has been authorized by FDA under an EUA for use by authorized laboratories; 
iii. The text has been authorized only for the diagnosis of Zika virus infection and not for any other viruses or pathogens; 
iv.  The test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection of the Zika virus and/or diagnosis of Zika virus infection under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.